NCT05264116

Brief Summary

The purpose of this clinical study is to validate the SpO2 accuracy of the Stryker Sustainability Solutions pulse oximetry sensors during motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. The end goal is to provide supporting documentation for the SpO2 accuracy validation of the reprocessed sensors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2022

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2022

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

February 22, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 3, 2022

Completed
1 year until next milestone

Results Posted

Study results publicly available

March 10, 2023

Completed
Last Updated

May 20, 2025

Status Verified

February 1, 2023

Enrollment Period

1 day

First QC Date

February 22, 2022

Results QC Date

February 9, 2023

Last Update Submit

May 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Sensor by Arms Calculation Under Motion Conditions

    Percentage of SpO2 (oxygen saturation by pulse oximetry) measured by the Reprocessed Oximeter pulse oximetry sensors during motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. Accuracy root mean square (ARMS) between measured SpO2 and reference SaO2 (arterial oxygen saturation) must meet the 3% specification for each reprocessed pulse oximetry sensor style. Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square error (Arms) value. Standard deviation of the differences is computed as the precision. Square root of the sum of the squares of bias and precision is computed as the Arms Error value.

    1-2 hours

Study Arms (1)

Healthy adult participants

EXPERIMENTAL

All participants are enrolled in the test group and receive the noninvasive adhesive reprocessed pulse oximeter sensors.

Device: STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERS

Interventions

Reprocessed noninvasive pulse oximeter sensors.

Healthy adult participants

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Good general health with no evidence of pre-existing medical problems
  • Fluent in both written and spoken English
  • Must be able to review informed consent and is willing to comply with study procedures

You may not qualify if:

  • Obesity (BMI \>30)
  • Known history of heart disease, lung disease, kidney or liver disease
  • Prior diagnosis of asthma, sleep apnea, or use of CPAP
  • Diabetes
  • Clotting disorder
  • Hemoglobinopathy or history of anemia that in the opinion of the investigators would make them unsuitable for study participation
  • Any serious systemic illness
  • Current smoker
  • Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigator would interfere with the sensors working correctly
  • History of fainting or vasovagal response
  • History of sensitivity to local anesthesia
  • Prior diagnosis of Raynaud's disease
  • Unacceptable collateral circulation based on exam by investigators (Allen's test)
  • Pregnant, lactating, or trying to get pregnant
  • Unable or unwilling to provide informed consent, or unable or unwilling to comply with study procedures
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Hypoxia Research Laboratory

San Francisco, California, 94133, United States

Location

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Monique Ketcher
Organization
Stryker Sustainability Solutions

Study Officials

  • Philip E Bickler, MD, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2022

First Posted

March 3, 2022

Study Start

February 2, 2022

Primary Completion

February 3, 2022

Study Completion

February 3, 2022

Last Updated

May 20, 2025

Results First Posted

March 10, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations